Based on the above findings, this study hypothesizes that hBMSC-derived exosomal miR-187 may eliminate the growth and metastasis of prostate cancer via modulation of the CD276-dependent JAK3-STAT3-Slug pathway. The gene discussed is JAK3; the disease is prostate cancer.